...ost cancers cells. ER and PR are markers of estrogen-dependent tumor growth and sensitivity to endocrine remedy with selective estrogen receptor modulators or aromatase inhibitors whic...
...st cancer cells. ER and PR are markers of estrogen-dependent tumor progress and sensitivity to endocrine remedy with selective estrogen receptor modulators or aromatase inhibitors whic...